These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 34819000)
1. Chromone, A Privileged Scaffold in Drug Discovery: Developments in the Synthesis and Bioactivity. Benny AT; Arikkatt SD; Vazhappilly CG; Kannadasan S; Thomas R; Leelabaiamma MSN; Radhakrishnan EK; Shanmugam P Mini Rev Med Chem; 2022; 22(7):1030-1063. PubMed ID: 34819000 [TBL] [Abstract][Full Text] [Related]
2. Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review. Mathew B; Mathew GE; Petzer JP; Petzer A Comb Chem High Throughput Screen; 2017; 20(6):522-532. PubMed ID: 28245770 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Legoabe LJ; Petzer A; Petzer JP Eur J Med Chem; 2012 Mar; 49():343-53. PubMed ID: 22309913 [TBL] [Abstract][Full Text] [Related]
4. Selected chromone derivatives as inhibitors of monoamine oxidase. Legoabe LJ; Petzer A; Petzer JP Bioorg Med Chem Lett; 2012 Sep; 22(17):5480-4. PubMed ID: 22850212 [TBL] [Abstract][Full Text] [Related]
5. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors. Gaspar A; Reis J; Fonseca A; Milhazes N; Viña D; Uriarte E; Borges F Bioorg Med Chem Lett; 2011 Jan; 21(2):707-9. PubMed ID: 21194943 [TBL] [Abstract][Full Text] [Related]
6. Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase-B inhibitors. Sudevan ST; Rangarajan TM; Al-Sehemi AG; Nair AS; Koyiparambath VP; Mathew B Arch Pharm (Weinheim); 2022 Aug; 355(8):e2200084. PubMed ID: 35567313 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 3-styrylchromone derivatives as selective monoamine oxidase B inhibitors. Takao K; Takemura Y; Nagai J; Kamauchi H; Hoshi K; Mabashi R; Uesawa Y; Sugita Y Bioorg Med Chem; 2021 Jul; 42():116255. PubMed ID: 34119696 [TBL] [Abstract][Full Text] [Related]
8. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. Gaspar A; Silva T; Yáñez M; Vina D; Orallo F; Ortuso F; Uriarte E; Alcaro S; Borges F J Med Chem; 2011 Jul; 54(14):5165-73. PubMed ID: 21696156 [TBL] [Abstract][Full Text] [Related]
9. Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors. Reis J; Cagide F; Chavarria D; Silva T; Fernandes C; Gaspar A; Uriarte E; Remião F; Alcaro S; Ortuso F; Borges F J Med Chem; 2016 Jun; 59(12):5879-93. PubMed ID: 27244485 [TBL] [Abstract][Full Text] [Related]
10. New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door. Mathew B; Carradori S; Guglielmi P; Uddin MS; Kim H Curr Med Chem; 2021; 28(2):266-283. PubMed ID: 31965939 [TBL] [Abstract][Full Text] [Related]
11. Syntheses and Evaluation of 2- or 3-(N-Cyclicamino)chromone Derivatives as Monoamine Oxidase Inhibitors. Takao K; Sakatsume T; Kamauchi H; Sugita Y Chem Pharm Bull (Tokyo); 2020; 68(11):1082-1089. PubMed ID: 33132375 [TBL] [Abstract][Full Text] [Related]